vs

Side-by-side financial comparison of Mayville Engineering Company, Inc. (MEC) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

Mayville Engineering Company, Inc. is the larger business by last-quarter revenue ($134.3M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -3.2%, a 6.6% gap on every dollar of revenue. On growth, Mayville Engineering Company, Inc. posted the faster year-over-year revenue change (10.7% vs 4.7%). Mayville Engineering Company, Inc. produced more free cash flow last quarter ($10.2M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -8.8%).

Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

MEC vs NATR — Head-to-Head

Bigger by revenue
MEC
MEC
1.1× larger
MEC
$134.3M
$123.8M
NATR
Growing faster (revenue YoY)
MEC
MEC
+5.9% gap
MEC
10.7%
4.7%
NATR
Higher net margin
NATR
NATR
6.6% more per $
NATR
3.3%
-3.2%
MEC
More free cash flow
MEC
MEC
$2.6M more FCF
MEC
$10.2M
$7.6M
NATR
Faster 2-yr revenue CAGR
NATR
NATR
Annualised
NATR
5.6%
-8.8%
MEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MEC
MEC
NATR
NATR
Revenue
$134.3M
$123.8M
Net Profit
$-4.4M
$4.1M
Gross Margin
6.8%
72.5%
Operating Margin
-4.1%
4.3%
Net Margin
-3.2%
3.3%
Revenue YoY
10.7%
4.7%
Net Profit YoY
-127.3%
1379.4%
EPS (diluted)
$-0.22
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MEC
MEC
NATR
NATR
Q4 25
$134.3M
$123.8M
Q3 25
$144.3M
$128.3M
Q2 25
$132.3M
$114.8M
Q1 25
$135.6M
$113.2M
Q4 24
$121.3M
$118.2M
Q3 24
$135.4M
$114.6M
Q2 24
$163.6M
$110.6M
Q1 24
$161.3M
$111.0M
Net Profit
MEC
MEC
NATR
NATR
Q4 25
$-4.4M
$4.1M
Q3 25
$-2.7M
$5.3M
Q2 25
$-1.1M
$5.3M
Q1 25
$20.0K
$4.7M
Q4 24
$16.0M
$-321.0K
Q3 24
$3.0M
$4.3M
Q2 24
$3.8M
$1.3M
Q1 24
$3.2M
$2.3M
Gross Margin
MEC
MEC
NATR
NATR
Q4 25
6.8%
72.5%
Q3 25
11.0%
73.3%
Q2 25
10.3%
71.7%
Q1 25
11.3%
72.1%
Q4 24
8.9%
72.0%
Q3 24
12.6%
71.3%
Q2 24
13.6%
71.4%
Q1 24
13.0%
71.2%
Operating Margin
MEC
MEC
NATR
NATR
Q4 25
-4.1%
4.3%
Q3 25
0.0%
7.0%
Q2 25
0.1%
3.7%
Q1 25
1.2%
5.4%
Q4 24
19.0%
3.8%
Q3 24
4.2%
4.6%
Q2 24
5.0%
5.1%
Q1 24
4.7%
4.2%
Net Margin
MEC
MEC
NATR
NATR
Q4 25
-3.2%
3.3%
Q3 25
-1.9%
4.2%
Q2 25
-0.8%
4.6%
Q1 25
0.0%
4.2%
Q4 24
13.2%
-0.3%
Q3 24
2.2%
3.8%
Q2 24
2.3%
1.2%
Q1 24
2.0%
2.1%
EPS (diluted)
MEC
MEC
NATR
NATR
Q4 25
$-0.22
$0.23
Q3 25
$-0.13
$0.30
Q2 25
$-0.05
$0.28
Q1 25
$0.00
$0.25
Q4 24
$0.76
$-0.02
Q3 24
$0.14
$0.23
Q2 24
$0.18
$0.07
Q1 24
$0.16
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MEC
MEC
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$1.5M
$93.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$240.7M
$161.6M
Total Assets
$563.6M
$261.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MEC
MEC
NATR
NATR
Q4 25
$1.5M
$93.9M
Q3 25
$1.2M
$95.6M
Q2 25
$206.0K
$81.3M
Q1 25
$183.0K
$86.5M
Q4 24
$206.0K
$84.7M
Q3 24
$178.0K
$78.7M
Q2 24
$314.0K
$68.7M
Q1 24
$314.0K
$77.8M
Total Debt
MEC
MEC
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$2.1M
Stockholders' Equity
MEC
MEC
NATR
NATR
Q4 25
$240.7M
$161.6M
Q3 25
$244.8M
$166.7M
Q2 25
$246.8M
$163.7M
Q1 25
$250.0M
$167.1M
Q4 24
$251.8M
$161.0M
Q3 24
$238.4M
$162.6M
Q2 24
$238.1M
$156.4M
Q1 24
$234.0M
$159.7M
Total Assets
MEC
MEC
NATR
NATR
Q4 25
$563.6M
$261.1M
Q3 25
$585.6M
$264.8M
Q2 25
$433.7M
$254.9M
Q1 25
$447.7M
$252.7M
Q4 24
$445.6M
$240.9M
Q3 24
$466.0M
$245.3M
Q2 24
$488.2M
$235.8M
Q1 24
$499.9M
$247.3M
Debt / Equity
MEC
MEC
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MEC
MEC
NATR
NATR
Operating Cash FlowLast quarter
$13.4M
$9.9M
Free Cash FlowOCF − Capex
$10.2M
$7.6M
FCF MarginFCF / Revenue
7.6%
6.1%
Capex IntensityCapex / Revenue
2.4%
1.9%
Cash ConversionOCF / Net Profit
2.41×
TTM Free Cash FlowTrailing 4 quarters
$26.9M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MEC
MEC
NATR
NATR
Q4 25
$13.4M
$9.9M
Q3 25
$1.9M
$18.5M
Q2 25
$15.0M
$4.3M
Q1 25
$8.3M
$2.6M
Q4 24
$38.0M
$12.2M
Q3 24
$17.9M
$9.6M
Q2 24
$23.3M
$1.3M
Q1 24
$10.6M
$2.2M
Free Cash Flow
MEC
MEC
NATR
NATR
Q4 25
$10.2M
$7.6M
Q3 25
$-1.1M
$16.8M
Q2 25
$12.5M
$3.0M
Q1 25
$5.4M
$1.5M
Q4 24
$35.6M
$10.0M
Q3 24
$15.1M
$7.9M
Q2 24
$19.2M
$-2.0M
Q1 24
$7.8M
$-1.5M
FCF Margin
MEC
MEC
NATR
NATR
Q4 25
7.6%
6.1%
Q3 25
-0.8%
13.1%
Q2 25
9.5%
2.6%
Q1 25
4.0%
1.3%
Q4 24
29.4%
8.5%
Q3 24
11.1%
6.9%
Q2 24
11.7%
-1.9%
Q1 24
4.9%
-1.4%
Capex Intensity
MEC
MEC
NATR
NATR
Q4 25
2.4%
1.9%
Q3 25
2.1%
1.3%
Q2 25
1.8%
1.2%
Q1 25
2.2%
1.0%
Q4 24
1.9%
1.9%
Q3 24
2.1%
1.5%
Q2 24
2.5%
3.0%
Q1 24
1.7%
3.3%
Cash Conversion
MEC
MEC
NATR
NATR
Q4 25
2.41×
Q3 25
3.46×
Q2 25
0.81×
Q1 25
416.65×
0.55×
Q4 24
2.38×
Q3 24
6.03×
2.21×
Q2 24
6.15×
0.97×
Q1 24
3.28×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MEC
MEC

Fabrication$72.2M54%
Construction And Access$19.2M14%
Tubes$16.2M12%
Other Market$11.9M9%
Agriculture$7.7M6%
Military$6.7M5%
Outdoor Sports$1.7M1%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons